Core Insights - Branded Legacy, Inc. has acquired a 22,000-square-foot commercial property in Vancouver, Canada, to establish a state-of-the-art laboratory and manufacturing facility aimed at addressing the opioid crisis [1][2] - The facility is compliant with Good Manufacturing Practices (GMP) and features ISO Class 7 and 8 clean rooms, ensuring high-quality standards for sensitive manufacturing processes [1][3] - The in-house laboratory is equipped to handle a variety of substances, including opioids, and the company has pending applications for Controlled Substances Licenses with Health Canada [4] - The strategic location in Vancouver allows for direct collaboration with local populations affected by the drug crisis, enhancing the relevance of the solutions developed [5] - Company executives emphasize that this acquisition aligns with their vision to create a comprehensive ecosystem for addiction solutions, combining expertise with academic partnerships and advanced manufacturing capabilities [6] Company Overview - Branded Legacy, Inc. focuses on health and wellness, developing innovative solutions to combat addiction, including a patented intranasal naloxone delivery device for opioid overdose treatment [7]